ArticleRadiation oncology (London, England)2018

A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma.

Rohann J M Correa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.